Live
- Time is right for BJP to make an entry into Kerala: Amit Shah
- REC okays Rs 1,869 crore loan for Kiru hydro project in J&K
- Nepal, Qatar agree to increase cooperation in various sectors
- 10 Effective and Gentle Techniques to Discipline Kids
- Six-year-old girl allegedly molested by tuition teacher's son in south Delhi
- Recording co's appeal in Madras HC casts a shadow on Ilaiyaraaja's 4.5K songs
- Turkish police detain 11 suspected IS members
- Vice FMs of South Korea, Canada discuss cooperation in energy, G7 ties
- HUL posts 6 pc fall in Q4 net profit at Rs 2,406 crore, declares dividend of Rs 24 per share
- Zimbabwe name 15-member squad for five-match T20I series against Bangladesh
New factor in liver cancer progression discovered
Researchers from the Medical University of Vienna in Austria have discovered a new factor in the development and progression of the most common type of liver cancer, hepatocellular carcinoma (HCC), the university said.
Researchers from the Medical University of Vienna in Austria have discovered a new factor in the development and progression of the most common type of liver cancer, hepatocellular carcinoma (HCC), the university said.
The team from the Institute of Cancer Research found the AXL receptor tyrosine kinase both supported cancer-advancing processes and inhibited anti-cancer mechanisms, Xinhua reported citing the university statement issued Thursday.
Team leader Wolfgang Mikulits said he was surprised the function of the AXL receptor now hardly had to be studied as the receptor was found to be activated in more than 50 percent of HCC patients.
The team was able to demonstrate that the presence and activation of the receptor led to a switch of signalling pathways that allowed for the migration and metastasis of liver cancer cells, as well as disabled the anti-cancer activity of the protein TGF beta.
An analysis of tumour samples from patients confirmed the experimental data.
